
HPV Vaccination in Latin America: Global Challenges and Feasible Solutions
2019; American Society of Clinical Oncology; Issue: 39 Linguagem: Inglês
10.1200/edbk_249695
ISSN1930-7020
Autores Tópico(s)Hepatitis B Virus Studies
ResumoHPV vaccine programs in Latin America run the risk of repeating the problems associated with Papanicolaou (Pap) test programs, an efficient, life-saving tool that is unfortunately underutilized for cancer prevention, in low- and middle-income countries. There is a great need for vigilance in the ongoing implementation of the HPV vaccine in Latin America.
Referência(s)